Kynurenine-3-hydroxylase and Its Selective Inhibitors: Molecular Modeling Studies

Advances in Experimental Medicine and Biology

Volumn 398, Issue , 1996, Pages 493-497

  Costantino, G ^a   Mattoli, L ^a   Moroni, F ^b   Natalini, B ^a   Pellicciari, R ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ENZYME INHIBITOR; KYNURENINE; KYNURENINE 3 MONOOXYGENASE; MIXED FUNCTION OXIDASE; NEUROPROTECTIVE AGENT;

ANIMAL; ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; PROTEIN CONFORMATION;

ANIMALS; BINDING SITES; DRUG DESIGN; ENZYME INHIBITORS; KYNURENINE; KYNURENINE 3-MONOOXYGENASE; MIXED FUNCTION OXYGENASES; MODELS, MOLECULAR; NEUROPROTECTIVE AGENTS; PROTEIN CONFORMATION;

EID: 0030332542     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0381-7_76     Document Type: Article

References (9)

1. Entsch, B.; Ballou, D. P.; Massey, V., 1976, Flavin oxygen derivatives involved in hydroxylation by p-hydroxybenzoate hydroxylase. J. Biol. Chem. 251: 2550.
2. Foster, A. C.; Vezzani, A.; French, E. D.; Schwarcz, R., 1984, Kynurenic acid blocks neurotoxicity and seizures induced in rat by the related brain metabolite quinolinic acid. Neurosci. Lett. 48: 273
3. Nozaki, K.; Beal, M., F., 1992, Neuroprotective effects of L-Kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats. J. Cerebr. Blood Flow Metab. 12: 400
4. Pellicciari, R.; Gallo-Mezo, M. A.; Natalini, B.; Amer, A. M., 1992, Stereospecific synthesis of the enantiomers of nicotinoylalanine, a neuroprotective agent. Tetrahedron Lett. 33: 3003
5. Pellicciari, R.; Natalini, B.; Costantino, G.; Mahmoud, R. M.; Mattoli, L.; Sadeghpour, B. M.; Moroni, F.; Chiarugi, A.; Carpenedo, R., 1994, Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase. J. Med. Chem. 37: 647
6. Russi, P.; Alesiani, M.; Lombardi G.; Davolio, P.; Pellicciari, R.; Moroni, F., 1992, Nicotinoylalanine increases the formation of the kynurenic acid in the brain and antagonizes convulsions. J. Neurochem. 59: 2076
7. Schreuder, H. A.; van der Laan, J. M.; Hol, W. G. J.; Drenth, J., 1988, Crystal structure of p-hydroxybenzoate hydroxylase complexed with its reaction product 3,4-dihydroxybenzoate. J. Mol. Biol. 199: 637
8. Schwarcz, R., 1993, Metabolism and function of brain kynurenines. Biochem. Soc. Trans. 21:77
9. Snyder, J. P., Rao, S. N.; Koehler, K. F.; Vedani, A., 1993, Minireceptors and Pseudoreceptors in "3D-QSAR in Drug Design", Kubinyi H., Ed. Escom, Leiden.